We reported earlier on the development of cell-mediated immunity (CMI) during experimental infection with Nocardia asteroides in guinea pigs (5) and after immunization with its ribonucleic acid protein (P-RNA) fraction (6) . CMI was protective as shown by the survival of guinea pigs passively immunized by spleen cell transfer and by a decrease in Nocardia tissue counts in the different organs. We have now investigated the role of macrophages in affording such protection (1) by measuring in vivo multiplication of Nocardia organisms in peritoneal macrophages after an intraperitoneal challenge with N. asteroides organisms in normal and immunized guinea pigs and (ii) by observing the effect of antimacrophage sera (AMS) on the survival of immunized guinea pigs challenged with N. asteroides and the multiplication of Nocardia organisms in different tissues of these animals.
MATERIALS AND METHODS Animals. Healthy outbred guinea pigs of both sexes, weighing 350 to 400 g and bred in our central animal house, were used. They were given a diet of Bengal gram and vegetables. Young adult white rabbits, weighing 1.5 to 2 kg and also bred in our central animal house, were used for preparing AMS. Bacteria. N. asteroides suspensions were used for challenge, and Listeria monocytogenes was used for the assay of microbicidal activity in control and immune macrophages as described previously (4, 5) .
Immunogens, immunization procedures, and CMI measurements. Techniques similar to those described earlier were used (5, 6) . Suspensions of live N. asteroides and P-RNA fraction were used as immunogens. Guinea pigs were actively immunized with live N. asteroides or P-RNA. Passive immunization was carried out by immune spleen cell transfer from these actively immunized animals. CMI was measured by using the macrophage migration inhibition (MMI) test and by macrophage microbicidal activity. The latter was assayed by the technique described by Simon and Sheagren (4) . MMI Preparation of AMS. AMS was prepared in rabbits to determine the effect of prior administration of AMS (i.e., before immunization in the above groups of actively and passively immunized animals) on their survival and on tissue counts in lungs, liver, spleen, heart, and kidneys. The following procedure, as described by Pearson and Osebold (2), was used. First, peritoneal macrophages were induced and harvested as follows. A 20-ml amount of brain heart infusion broth, containing 3% peptone (Difco Laboratories), was injected intraperitoneally into normal guinea pigs. PEC were collected 2 days later in Hanks BSS containing heparin (5 U/ml). They were washed in Hanks BSS and suspended in enriched Eagle minimal essential medium. PEC were then cultured in 50-ml conical flasks incubated at 37°C in the presence of 5% CO2. The medium was changed after 1, 24, and 48 h, removing the nonadherent cells. After 4 days, the remaining adherent cells were collected by scraping with a rubber policeman. They were washed and suspended in minimal essential medium containing no serum. The viability was checked by the trypan blue dye exclusion method, and the viable macrophages were counted. More than 95% of the cells were viable. These macrophages were injected intravenously into the rabbits in doses ranging from 107 to 3 x 107 cells. A second injection was given 14 days later. Seven days after the last injection, the sera were collected, inactivated at 560C for 30 min, and stored at -700C. The macrophage antisera were tested for their cytotoxicity and hemagglutinating activity.
Macrophage cytotoxicity assay of AMS. The macrophage cytotoxicity assay was carried out using the method described by Pearson and Osebold (2) . PEC obtained from normal guinea pigs were washed, suspended in Hanks BSS, and adjusted to a concentration of 106 cells per ml. Twofold serial dilutions of AMS were made in Hanks BSS. To 0.5 ml of different dilutions of AMS 0.5 ml of macrophage suspension (PEC) was added, and the mixture was incubated at 370C for 30 min. After incubation, 0.1 ml of pooled fresh guinea pig complement was added, and the mixture was reincubated at 370C for 30 min. At the end of this time, 0.2 ml of 0.4% trypan blue in Hanks BSS was added, mixed, and kept for 5 to 10 min. It was filled in a Neubar counting chamber and the number of dead cells was counted under a light Olympus microscope using x400 magnification and bright-field optics. The reaction was judged to be cytotoxic when 50% or more of the cells were stained by trypan blue. The log of the reciprocal of the highest dilution of AMS which caused cytotoxicity was designated as the titer. The AMS contained high titers of cytotoxic antibodies to macrophages. The cytotoxic titer for macrophages was 27. It contained little cytotoxic activity against lymphocytes; the titer was only 23.
Hemagglutination test. The hemagglutinating activity of AMS was tested according to the procedure described by Pearson and Osebold (3) . Freshly collected guinea pig blood was washed three times in a 0.85% NaCl solution containing heparin (5 U/ml). Twofold serial dilutions of AMS were made in minimal essential medium containing 0.1% bovine serum albumin, using microtiter plates. A 0.05-ml amount of 1% guinea pig erythrocytes was added to an equal volume of diluted (vol/vol) serum in each well. After mixing, the plates were incubated at 37°C for 30 min. The highest dilution of serum which caused 50% of the cells to agglutinate was recorded as the titer. AMS also possessed hemagglutinating activity up to a titer of 24.
RESULTS
The effect of immunization on in vivo intracellular killing of N. asteroides by peritoneal macrophages in different groups of guinea pigs after intraperitoneal challenge with 107 Nocardia organisms was as follows.
(i) Guinea pigs immunized with P-RNA and challenged intraperitoneally with live N. asteroides at different time intervals after determining the CMI. N. asteroides counts were done in the peritoneal macrophages collected 2 and 72 h after challenge ( (Table 2 ). There was a 1.8-to 8-fold increase in the number of bacteria in these macrophages.
(ii) Guinea pigs passively immunized by transfer of immune spleen cells from P-RNA-immunized animals ( Table 2 ). To eliminate the effect of humoral immunity, immune spleen cells were passively transferred from P-RNA-immunized donor guinea pigs (no. 190 and 191) and the recipients (no. 194 to 199) were challenged intraperitoneally with N. asteroides. In these recipients, there was considerable intracellular killing of N. asteroides in macrophages. The 2-and 72-h intracellular counts varied from 3,950 to 7,750 and from 455 to 1,500, respectively. The decrease in the 72-h count ranged from 3.9-to 17-fold (P < 0.001).
(iii) Guinea pigs passively immunized by transfer of immune spleen cells from donors which had been actively immunized with live N. asteroides ( 'Immune macrophages stimulated with P-RNA show decrease in 4-h Listeria count or intracellular killing. ' Marked decrease in 72-h Nocardia count showing intracellular killing. 'Enhancement of MMI (percentage). challenge (Tables 3 and 4) . Normal unimmunized guinea pigs, not treated with AMS but challenged with N. asteroides (no. 165, 166, and 167), became sick in 7 to 10 days and died in 15 days. Normal unimmunized guinea pigs treated with AMS and challenged with N. asteroides (no. 242, 243, and 256 to 259) became very sick and died in 5 days. Three days after challenge, there was an increase in the number of N. asteroides in lungs, heart, kidneys, liver, and spleen. Total tissue counts in different organs in 3 or 5 days (just before death) after N. asteroides challenge are shown in Table 3 . When animals immunized with P-RNA were challenged after AMS treatment (no. 223 to 230), they became sick in 3 days and died in 5 days. The various organs showed a large number of Nocardia organisms. There was no significant difference in the number of Nocardia organisms in different organs in AMS-treated, control immunized animals sacrificed in 3 days: lungs, P = 0.2; heart, P = 0.2; kidneys, P = 0.2; liver, P= 0.2; spleen, P = 0.2. In animals dying in 5 days, the P values for Nocardia tissue counts in lungs, heart, liver, kidneys, and spleen were >0.5.
Effect of AMS on Nocardia tissue counts after N. asteroides challenge in guinea pigs passively immunized by transfer of spleen cells from donors actively immunized with P-RNA (Table 3) . Recipient guinea pigs containing immune cells passively transferred from spleens of P-RNA-immunized guinea pigs and challenged after AMS treatment (no. 244 to 249 and 251 to 254) became sick in 3 days and died in 5 to 6 days. In 3 days, however, there was an initial reduction in the number of Nocardia in lungs (P = 0.001), liver (P = 0.001), and spleen (P = 0.001). There was no significant difference in the number of bacteria in heart (P = 0. tracardially became sick in 5 to 7 days and died in 15 days, with gross lesions in lungs, heart, and kidneys. When, however, the guinea pigs were actively or passively immunized and later challenged with N. asteroides, they survived for at least up to 60 days. In such animals, the different tissues, i.e., liver, lungs, heart, spleen, and kidneys, showed little or no growth of N. asteroides on sacrifice at different time intervals. We have now found that these Nocardia are eliminated specifically by immune macrophages in immunized animals. Furthermore, it is seen that administration of AMS before challenge with N. asteroides in actively and passively immunized animals nullified the protective effect of immunization. After administration of AMS and later intravenous N. asteroides challenge, the actively or passively immunized animals became sick in 3 days and died in 5 days. The total Nocardia count in different tissues such as heart, liver, spleen, and kidneys showed no significant differences in immunized and AMS-treated control animals. After administration of AMS, N. asteroides multiplied as freely in immunized animals as in unimmunized controls.
It should also be stated that some investigators (2, 3) have failed to obtain significant alterations in immune responses by AMS in in vivo experiments. The enhanced mortality after AMS injection in our study could also be partly the effect of antilymphocyte antibodies in AMS or T-cell loss. It is felt that our data only establish that a resistance mechanism is operating and that it can be transferred with spleen cells. It could be that the microbial counts performed on cells washed from the peritoneal cavity do not necessarily establish that death occurs intracellularly, even though AMS was shown to interfere with host resistance.
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